ProfileGDS5822 / ILMN_2974016
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 16% 7% 12% 5% 6% 21% 38% 0% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.716
GSM1276600PDAC Late Ablation Control 210.87
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.412
GSM1276603PDAC Late Ablation 26.35
GSM1276604PDAC Late Ablation 36.16
GSM1303940PDAC Late Ablation_anti-CTLA4 113.221
GSM1303941PDAC Late Ablation_anti-CTLA4 218.138
GSM1303942PDAC Late Ablation_anti-CTLA4 30.10